-
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
-
2022-501254-10-00
5
2018-08-24
Advanced tumors
-
2024-520050-38-00
5
2025-09-18
Extensive stage small cell lung cancer (ES-SCLC). S
-
2023-505989-29-00
5
2024-11-21
Extensive stage small cell lung cancer (ES-SCLC)
-
2023-503714-77-00
4
2024-10-01
Advanced Non-Small Cell Lung Cancer
-
2023-503357-35-00
4
2024-03-20
Non-small Cell Lung Cancer (NSCLC)
-
2022-502669-14-00
5
2023-12-18
Small cell lung cancer (SCLC)
-
2022-501863-41-00
5
2023-11-13
Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non–Small
-
2022-500802-16-00
5
2023-11-01
Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung
-
2024-515047-31-00
5
2023-08-28
Patients with Limited-Stage Small Cell Lung Cancer (LS-SCLC) at stage
-
2022-501506-36-00
5
2023-04-11
First-line treatment of participants with metastatic nonsmall cell lun
-
2024-514173-22-00
5
2023-02-28
Cystic Fibrosis
-
2023-505057-40-00
4
2022-12-02
Lung Cancer, Non-Small Cell
-
2023-509429-37-00
5
2022-10-03
Advanced or Metastatic Non-Small Cell Lung Cancer
-
2023-507933-12-00
5
2022-08-18
Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
-
2023-503517-30-00
5
2022-04-01
Extensive-stage small-cell lung cancer
-
2023-503868-16-00
5
2022-02-14
Small-Cell Lung Cancer (SCLC)
-
2023-508308-40-00
5
2021-07-30
Metastatic (stage IV) squamous or nonsquamous non-small cell lung canc
-
2023-504959-27-00
5
2020-12-09
Participants with Limited Stage-Small Cell Lung Cancer, who have recei
-
2024-511798-31-00
7
2019-05-31
KRAS p.G12C Mutant Advanced Solid Tumors
-
2023-509576-42-00
5
2019-02-21
Patients with resectable Non-small Cell Lung Cancer (Stage IIA to IIIB
-
2023-506186-57-00
5
2017-09-04
Cancer (Future parent protocols may include other cancer that are not
-
2023-505981-26-00
5
2015-11-20
Non−Small Cell Lung Cancer
-
2023-503298-39-00
5
2024-06-13
Metastatic Non-Small Cell Lung Cancer (mNSCLC)